Manufacturer record

Chiros Pharma: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Chiros Pharma (Himachal Pradesh) were declared Not of Standard Quality between March 2019 and October 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

3 records linked to Chiros Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2019 to Oct 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2019
3
Products affected
Assay
Most common failure
Oct 2024
Latest alert

Flagged batches per year

2019 · 22024 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
VRIZAROX-100DT Tablets Cefpodoxime Proxetil Dispersible Tablets CABQ4001Mfg 2024-01 · Exp 2025-12 MISBRANDED The monograph of Cefpodoxime Tablets in the current edition of Indian Pharamacopoeia i.e. IP-2022. is also applicable for Cefpodoxime Dispersible Tablets as indicated under labelling section of the monograph. However the firm failed to indicate the latters IP after the product name CefpodoximeDispersible Tablets. Hence, the drug is deemed to be Misbranded as per section 17 of the Drugs and Cosmetics Act, 1940, since it is not labeled in the prescribed mannar.Misbranded State Lab Drugs Control Laboratory, TelanganaState lab Oct 2024
Moxodin-CV Dry Syrup (Amoxycillin and Potassium Clavulanate Oral Suspension I.P.) MMAL9002Mfg 2018-07 · Exp 2019-12 Assay of AmoxycillinTrihy drateAssay CDL KolkataCDSCO lab Mar 2019
Almox-CV 625 (Amoxycillin and Potassium Clavulanate Tablets I.P.) TDCB8003Mfg 2017-12 · Exp 2019-11 Assay of Potassium Clavulanate&Dis sulution of Amoxicillin Trihydrate& Potassium ClavulanateAssay CDL KolkataCDSCO lab Mar 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.